has recently begun to unravel. Several molecular components of this pathway were initially identified in budding yeast, including Mad1, Mad2,
. of a cohesin protein by the separase destroys the coheElegant experiments on mammalian cells have resion between the sister chromatids and triggers the onvealed two extraordinary features of the mitotic checkset of anaphase (Uhlmann et al., 2000) . To ensure the point. First, as a single unattached kinetochore can dehigh-fidelity transmission of the genetic material, the lay the onset of sister chromatid separation, it must timing of sister chromatid separation is closely monigenerate an inhibitory signal to block the activity of APC tored by the spindle assembly or mitotic checkpoint (Rieder et al., 1995) . Moreover, this signal needs to be (Straight and Murray, 1997; Burke, 2000) . This checkdistributed throughout the cell to account for the inhibipoint senses the existence of kinetochores not yet occution of APC that is not associated with the unattached pied by microtubules (Gorbsky and Ricketts, 1993; Li kinetochore (Shah and Cleveland, 2000) . Although the and Nicklas, 1995; . A single unatnature of this diffusive inhibitory signal has not been tached kinetochore within a cell is sufficient to trigger established, it is likely to involve the Mad2 protein due this checkpoint, resulting in the inhibition of APC, the to its direct role in the inhibition of APC Cdc20 and its fast stabilization of securin, and the delay of the onset of turnover rate at unattached kinetochores (Howell et al., anaphase (Nicklas, 1997) . 2000). Second, one of the traits of the unattached kinetoThe molecular mechanism of the mitotic checkpoint chores that the checkpoint senses may be the lack of tension exerted by microtubules (Li and Nicklas, 1995) .
This notion is further strengthened by the recent finding that the kinesin-like motor CENP-E is an essential comkD BubR1 complex from nocodazole-treated HeLa cells. ponent of the mitotic checkpoint in mammalian cells
Using a combination of conventional and immunoaffinity and in Xenopus extracts (Abrieu et al., 2000; Yao et al., chromatography, the BubR1 complex was purified to 2000). CENP-E interacts directly with BubR1 in mitosis, homogeneity ( Figure 1C ). Based on Coomassie staining, and this interaction may be a part of the force-sensing only two bands, p150 and p40, appeared to be present mechanism (Chan et al., 1999; Yao et al., 2000) . However, at stoichiometric levels ( Figure 1D ). Identical banding it is unclear how an imbalance of force can be translated patterns were observed for two different antibodies into an activity that inhibits APC. against BubR1. The p150 and p40 proteins were subTo gain insight into the roles of the checkpoint projected to tryptic digestion followed by liquid chromatogteins in transducing the inhibitory kinetochore signal, raphy and tandem mass spectrometry (LC/MS/MS) analwe purified a 500 kD BubR1 complex from mitotic HeLa ysis and were identified with high confidence as human cell lysate using a combination of conventional and BubR1 and human Bub3, respectively. (Figure 2A) . Interestingly, BubR1 also on a gel filtration column. Bub1 eluted as part of a 1,000 blocked the activity of APC
Cdc20
. As controls, Bub1 and kD complex in HeLa cells treated with nocodazole, which Bub3 had no effect on APC activity. depolymerized microtubules and activated the spindle asWe next compared the potency of BubR1 and oligosembly checkpoint ( Figure 1A) . However, the Bub1 commeric Mad2 to inhibit APC
. To our surprise, BubR1 plex was also present in cells arrested at the G1/S inhibited APC Cdc20 at a much lower concentration (Ki ϭ boundary by thymidine. The fractionation profiles of 40 nM) than Mad2 (Ki ϭ 2 M), using either cyclin B1 APC2 and Mad2 in mitotic and G1/S lysates did not ( Figure 2B ) or human securin ( Figure 2C ) as substrates. vary, either. In contrast, while BubR1 existed as part of Based on quantitative immunoblotting, we estimated a 500 kD complex in G1/S cell lysate, a significant portion that the total concentrations of BubR1, Mad2, Cdc20, of BubR1 was incorporated into a larger complex (1,500 and APC2 in mitotic HeLa cells were around 90 nM, 120 kD) when the checkpoint was activated. Interestingly, nM, 100 nM, and 80 nM, respectively (see Supplemental the majority of Cdc20 eluted around 250 kD in G1/S Figure S1 at http://www.developmentalcell.com/cgi/ lysate. Upon checkpoint activation, Cdc20 formed two content/full/1/2/227/DC1). Therefore, BubR1 can inhibit additional larger complexes, which appeared to coelute APC Cdc20 at the physiological concentration. On the conwith the two forms of BubR1 complexes in the same trary, the concentration of Mad2 in mitotic HeLa cells lysate ( Figures 1A and 1B) .
is well below the Ki of 2 M, and is thus not sufficient Because BubR1 and Cdc20 exhibited a similar fractionation profile in mitosis, we decided to purify the 500 to inhibit APC Cdc20 in vivo without intervention from other When BubR1 was added to the interphase extracts together with ⌬90-cyclin B, the degradation of an N-termicomplex inhibited APC at similar concentrations (Figure 2B) . nal fragment of cyclin B1 was effectively blocked ( Figure  3C ). BubR1 did not block the activation of cyclin B/cdc2 BubR1 also inhibited human APC purified from synchronized HeLa cell lysates ( Figure 3A ). The addition of based on the H1 kinase assay ( Figure 3D ), indicating that BubR1 prevented the activation of APC at a later Cdc20 activated APC in S, G2, and early mitosis (Fang et al., 1998b) . When BubR1 protein was added together step. BubR1 also partially inhibited the degradation of cyclin B1 when added to the mitotic extracts ( Figure 3E ). with Cdc20, it blocked the ability of Cdc20 to stimulate However, this effect is less profound than that observed complex is formed, it becomes more resistant to the actions of BubR1. Mad2 appeared to inhibit APC with the interphase extracts, consistent with the fact that the mitotic APC was more resistant to the inhibition through a similar mechanism ( Figure 4B ). In addition, Cdc20 associated with the mitotic APC more strongly of BubR1.
than with the interphase APC because the binding of Cdc20 to mitotic APC was only blocked at higher conBubR1 Blocks Binding of Cdc20 to APC centrations of BubR1 or Mad2. This is presumably due We then investigated the mechanism by which BubR1 to the fact that multiple APC subunits become phosinhibited APC. BubR1 effectively blocked the binding of phorylated in mitosis, and phosphorylation may inCdc20 to the interphase APC ( Figure 4A by kinases to phosphorylate substrates. These results of BubR1, K795A, which was likely to disrupt its ability to bind ATP. As expected, the K795A mutation abolished suggested that BubR1 did not function catalytically. To confirm this, we constructed a kinase-inactive mutant the ability of BubR1 to autophosphorylate, suggesting Figure 5C ). This suggested that the region mutants of Cdc20 corresponding to the N-and C-termispanning residues 526-700 might be critical for the innal domains were then constructed ( Figure 6B ). The hibitory activity of BubR1. Alternatively, BubR1 might wild-type oligomeric Mad2 interacted strongly with the contain multiple Cdc20 binding sites. The latter possibil-N-terminal domain of Cdc20, as did a monomeric form of ity was more consistent with the fact that the BubR1d a Mad2 mutant (with the N-terminal ten residues deleted, fragment containing residues 351-700 had no inhibitory ⌬N10-Mad2). As a control, the Mad2 mutant with its activity toward APC ( Figure 5C ). Therefore, the APC-C-terminal ten residues deleted (⌬C10-Mad2) did not inhibitory region of BubR1 cannot be localized to a single bind to Cdc20. As expected, none of the Mad2 proteins small domain. However, a fragment of BubR1 lacking associated with the C-terminal WD40 domain of Cdc20. the entire kinase domain (BubR1f) was sufficient to inUnexpectedly, both the monomeric and oligomeric hibit APC, further supporting the notion that the kinase forms of Mad2 interacted only weakly with the intact activity of BubR1 was not required for APC inhibition.
Cdc20. The weak interaction between Mad2 and the intact Cdc20 was not due to the inability to form the Mad2-Cdc20 complex posttranslationally, because only Binding between BubR1 and Cdc20 Requires minor portions (about 20%) of Mad2 and Cdc20 were the Intact Cdc20 able to form a complex even when both proteins were We next examined the binding between Cdc20 and the coexpressed in Sf9 cells (data not shown). Similar results BubR1 fragments. To qualitatively compare the affinities of the BubR1-Cdc20 and Mad2-Cdc20 interactions, the were also obtained in a yeast two-hybrid assay (data between BubR1 and Cdc20 is established, which involves multiple contact sites between large segments In contrast, BubR1 did not bind to either the N-or C-terminal domains of Cdc20. However, it interacted of the BubR1 and Cdc20 proteins. We also mapped the region of BubR1 that was responstrongly with the intact Cdc20 ( Figure 6D ). The two BubR1 fragments that were sufficient to inhibit APC, sible for binding to Bub3. As shown in Figure 6D , BubR1a, BubR1d, and BubR1f interacted with Bub3. Therefore, BubR1b and BubR1f, also associated with Cdc20. Interestingly, although the BubR1d fragment did not inhibit the Bub3 binding region of BubR1 is likely to reside in residues 351-525. This is consistent with earlier findings APC, it appeared to be sufficient for binding to Cdc20. 
